Gilbert Marks
Direktor/Vorstandsmitglied bei AN2 THERAPEUTICS, INC.
Vermögen: 45 432 $ am 31.05.2024
Profil
Gilbert Lynn Marks is currently the Office Director at Biomedical Advanced Research & Development Authority and an Independent Director at AN2 Therapeutics, Inc. He previously served as the Chairman at Global Alliance for TB Drug Development from 2006 to 2018, Chairman-Cures Acceleration Network Review Board at National Center for Advancing Translational Sciences from 2016 to 2021, Director at Women Organized Against Rape from 2017 to 2021, Member-Scientific Review Board at MMV Medicines for Malaria Venture from 2020 to 2021, Senior Vice President-Research & Development at GlaxoSmithKline LLC from 1993 to 2017, and Vice President at Tunnell Government Services, Inc. from 2017 to 2021.
He obtained his undergraduate degree from Auburn University and his doctorate degree from the University of South Alabama.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
AN2 THERAPEUTICS, INC.
0,08% | 19.06.2024 | 22 830 ( 0,08% ) | 45 432 $ | 31.05.2024 |
Aktive Positionen von Gilbert Marks
Unternehmen | Position | Beginn |
---|---|---|
AN2 THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.02.2020 |
Biomedical Advanced Research & Development Authority | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Gilbert Marks
Unternehmen | Position | Ende |
---|---|---|
Tunnell Government Services, Inc.
Tunnell Government Services, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Government Services, Inc. provides assistance for government agencies. It Offer Services in public health preparedness and response, bioscience lab services, and scientific project portfolio management. The company was founded in June 2008 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01.09.2021 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | 01.09.2021 |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National Center for Advancing Translational Sciences studies translation on a system-wide level as a scientific and operational problem. The company was founded in 2012 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 01.01.2021 |
Women Organized Against Rape | Direktor/Vorstandsmitglied | 01.01.2021 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Vorsitzender | 01.01.2018 |
Ausbildung von Gilbert Marks
Auburn University | Undergraduate Degree |
University of South Alabama | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AN2 THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Commercial Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Biomedical Advanced Research & Development Authority | |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National Center for Advancing Translational Sciences studies translation on a system-wide level as a scientific and operational problem. The company was founded in 2012 and is headquartered in Rockville, MD. | Government |
Tunnell Government Services, Inc.
Tunnell Government Services, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Government Services, Inc. provides assistance for government agencies. It Offer Services in public health preparedness and response, bioscience lab services, and scientific project portfolio management. The company was founded in June 2008 and is headquartered in Bethesda, MD. | Commercial Services |
Women Organized Against Rape |